News About: Pharm. Affairs
The effect of Ezatimibecaused improved confidence…Atozet will be launched in Korea soon
It is noticed that a new hyperlipidemia complex drug will soon be launched as interconnecting with the research report proving effectiveness of non-statin type medicines on treating cardiovascular disorders.
Accordin...
The diabetic treatment ‘Janumet XR’ exceeded the annual sales of KRW 10 billion within a year
The MSD Korea’s (CEO Dong-wook Hyun) DDP-4 inhibitor, the sitagliptin/metformin extended release ‘Janumet XR’, recorded the annual sales of KRW 10.3 billion (based on the UBIST’s outpatient prescription expenses) in 2...
The domestic entry of the biosimilar of Lantus will create a powerful diabetic lineup for BI-Lilly
Boehringer Ingelheim and Lilly (hereinafter referring to BI-Lilly)are about to dominate the diabetic treatment market.
They are preparing entry of the biosimilar product of the Sanofi’s basal insulin release ‘Lantus ...
Generics went over the original ‘Stillen’… Two of them grew as the blockbuster level
Having the 2-year anniversary, generics of Stillen exceeded sales of the original ‘Stillen’.
That is, two Stillen generics are threatening the original by showing high growth rates, getting into the blockbuster level...
“We are opposing indirect expansion of places dealing with safety pharmaceutical products”
The Korean Pharmaceutical Association (KPA) has made a public announcement about the policy that the government is pushing forward to expand places to deal with safety pharmaceutical products.
The core idea is to opp...
The outpatient prescription expenses exceeded KRW 9 trillion last year
It is known that outpatient prescription expenses of the entire pharmaceutical companies exceeded KRW 9 trillion last year, which makes a small increase compared to the year before.
According to the analysis result o...
It will be allowed for condominiums and resorts to sell safety pharmaceutical products in March 2015
The Ministry of Health and Welfare (Minister Hyung-pyo Moon) will prepare and make pre-announcement of amendment related tothe enforcement regulation of notification duty to report death of pharmacists and oriental ph...
Will the number of OTC drug-specialized organizations increase?...The number of personnel focusing on OTC drug sales is expected to be expanded
It is noticed that domestic pharmaceutical companies have started to warm up the industry to invigorate OTC (Over The Counter) drugs.
This is because Dong-A Pharmaceutical and Hanmi Pharmaceutical runs the OTC indepe...
The emergence of a new treatment, which broke the one-year barrier of the survival period of cancer patients
A lung cancer treatment, which extended the survivalperiod of inexperienced patients to an epoch-making time, will enter the Korean market.
The product has received attention because it broke the one-year barrier in ...
After the president election of the Korea Pharmaceutical Distribution Association, it is inevitable to have conflicts with the pharmaceutical industry
After the president election of the Korea PharmaceuticalDistribution Association (KPDA), conflicts between the wholesale and pharmaceutical industry are expected to be inevitable.
The KPDA will hold a regular general...
